Patricio Rojas - Concepedia

Author

Patricio Rojas

Pontificia Universidad Católica de Chile ORCID

Also Known As

P Rojas, P. Jauregui Rojas, P. Rojas, Patricio Pérez Rojas, Patricio Rojas

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Pontificia Universidad Católica de Chile University Hospitals Seidman Cancer Center Case Western Reserve University Lentigen Technology (United States)Cleveland Clinic

About

Patricio Rojas is an author at Pontificia Universidad Católica de Chile specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	889
2	Public Health	3	3	142
3	Health Sciences	1	1	31
4	Blood Transplantation	1	1	14
5	Diabetes	1	1	531

Patricio Rojas

Publications

964

Citations

H-Index

Page 1

	Year	Citations
Mortality Risk Factors in Patients Treated by Chronic Hemodialysis Patrice Degoulet, M Legrain, I Réach, The Nephron journals/Nephron journals Weekly DialysisDialysisDialysis TherapyLogistic AnalysisMetabolic Syndrome	1982	531
Adolescent pregnancy: associations among body weight, zinc nutriture, and pregnancy outcome Flora F. Cherry, H H Sandstead, Patricio Rojas, American Journal of Clinical Nutrition Pregnancy NutritionNutritionAdolescent PregnancyTeenage PregnancyMedicine	1989	110
Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma Paolo F. Caimi, Gabriela Pacheco Sánchez, Ashish Sharma, Frontiers in Immunology ImmunologyImmune RegulationImmunoeditingCd4 T Cell ResponsesImmunotherapeutics	2021	109
Fundus Lesions in Malignant Hypertension Sohan Singh Hayreh, Gary E. Servais, Prem Singh Virdi, Ophthalmology HypertensionHistopathologyVascular MalformationPathologyFundus Lesions	1986	62
Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis Iván Palomo, Jaime Pereira, Marcelo Alarcón, Journal of Clinical Laboratory Analysis	2005	34
A phase II study of ramucirumab as first-line monotherapy in patients (pts) with advanced hepatocellular carcinoma (HCC). Andrew X. Zhu, RS Finn, M. F. Mulcahy, Journal of Clinical Oncology Vegf Receptor 2ImmunologyPathologyPhase Ii StudyHcc Pathogenesis	2010	31
JAK/STAT Pathway Inhibition May Be a Promising Therapy for COVID-19-Related Hyperinflammation in Hematologic Patients Patricio Rojas, M. Orrillo Sarmiento Acta Haematologica Promising TherapyImmunologyJak/stat Pathway InhibitorCovid-19 EpidemiologyImmunotherapy	2020	18
Non-Relapse Mortality in <i>TP53</i>-Mutated MDS/AML - a Multi-Center Collaborative Study Michael Byrne, Tony Kurian, Dilan A. Patel, Blood	2021	15
Alcoholism and socioeconomic status, hepatic damage, and arteriosclerosis. Study of 777 autopsied men in Santiago, Chile. B Viel, Sergio Donoso, Danilo Salcedo, PubMed Substance UseSocial Determinants Of HealthHepatic DamageAutopsied MenAlcohol Misuse	1966	14
Admission of Hematopoietic Cell Transplantation Patients to the Intensive Care Unit at the Pontificia Universidad Católica de Chile Hospital Karen Escobar, Patricio Rojas, Daniël Ernst, Biology of Blood and Marrow Transplantation Pontificia Universidad CatólicaChile HospitalTransplantationIntensive Care UnitSolid Organ Transplantation	2014	14

Page 1